Safety and tolerability of a 5 mg starting dose of vericiguat among patients with heart failure: the VELOCITY study
17 May 2025 (16:00 - 16:10)
Organised by: 
Slides
About the speaker
Duke Clinical Research Institute, Durham (United States of America)
6 More presentations in this session
Doctor A. Porcari (London, GB)
Professor I. Olivotto (Florence, IT)
Doctor J. Nunez Villota (Valencia, ES)
Doctor A. Muslin (Watertown, US)
Access the full session
The Event
Heart Failure 2025
17 May 2025
16:00 CET
You may be interested in
Congress Presentation
Congress Presentation
